S&Co Inc Alkermes Plc. Transaction History

S&Co Inc

$1.53 Billion
Q3 2024

A detailed history of S&Co Inc transactions in Alkermes Plc. stock. As of the latest transaction made, S&Co Inc holds 214,715 shares of ALKS stock, worth $6.38 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

214,715

Previous 214,715 -0.0%

Holding current value

$6.38 Million

Previous $5.17 Million 16.14%

% of portfolio

0.39%

Previous 0.36%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$23.21 - $27.24 $92,840 - $108,960	4,000 Added 1.9%	214,715 $5.17 Million
Q1 2024 May 09, 2024	BUY	$26.4 - $32.56 $991,848 - $1.22 Million	37,570 Added 21.7%	210,715 $5.7 Million
Q4 2023 Feb 12, 2024	BUY	$23.37 - $28.68 $470,788 - $577,758	20,145 Added 13.17%	173,145 $4.8 Million
Q2 2021 Jul 14, 2021	BUY	$18.78 - $25.15 $15,024 - $20,120	800 Added 0.53%	153,000 $3.75 Million
Q4 2020 Jan 28, 2021	BUY	$15.39 - $22.1 $153,900 - $221,000	10,000 Added 7.03%	152,200 $3.04 Million
Q2 2020 Dec 16, 2020	BUY	$13.31 - $19.41 $1.41 Million - $2.06 Million	106,000 Added 292.82%	142,200 $2.76 Million
Q1 2020 Apr 28, 2020	BUY	$13.06 - $21.24 $261,200 - $424,799	20,000 Added 123.46%	36,200 $522,000
Q3 2019 Oct 29, 2019	BUY	$19.51 - $24.28 $136,570 - $169,960	7,000 Added 76.09%	16,200 $316,000
Q2 2019 Jul 23, 2019	BUY	$21.47 - $37.33 $21,470 - $37,330	1,000 Added 12.2%	9,200 $207,000
Q3 2017 Nov 02, 2017	BUY	$49.16 - $54.45 $403,112 - $446,490	8,200	8,200 $417,000

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S&Co Inc, based on Form 13F filings with the SEC.

News

Stay updated on S&Co Inc with notifications on news.

Account